Dr. Samson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4500 San Pablo Rd S
Jacksonville, FL 32224Phone+1 904-953-2000
Education & Training
- Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2003 - 2006
- Queen's University at KingstonClass of 2000
Certifications & Licensure
- TX State Medical License 2006 - 2026
- FL State Medical License 2020 - 2025
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FACE) American Association of Clinical Endocrinology
Clinical Trials
- An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease. Start of enrollment: 2011 Aug 16
- An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly
- Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly Start of enrollment: 2014 May 23
- Join now to see all
Publications & Presentations
PubMed
- 171 citationsMultidisciplinary management of acromegaly: A consensus.Andrea Giustina, Garni Barkhoudarian, Albert Beckers, Anat Ben-Shlomo, Nienke R. Biermasz
Reviews in Endocrine & Metabolic Disorders. 2020-09-10 - 143 citationsA Pituitary Society update to acromegaly management guidelinesMaria Fleseriu, Beverly M. K. Biller, Pamela U. Freda, Mônica R. Gadelha, Andrea Giustina
Pituitary. 2021-02-01 - 195 citationsGhrelin: much more than a hunger hormone.Geetali Pradhan, Susan L. Samson, Yuxiang Sun
Current Opinion in Clinical Nutrition and Metabolic Care. 2013-11-01
Press Mentions
- Chiasma Announces Publication of Pivotal Data from the Phase 3 CHIASMA OPTIMAL Clinical Trial in the Journal of Clinical Endocrinology & MetabolismAugust 17th, 2020
- Drug Made by Massachusetts Company Will Help People with Rare Overgrowth DiseaseJuly 5th, 2020
- First Oral Somatostatin Analogue Approved for AcromegalyJune 30th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: